These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27025413)

  • 1. Picrasidine N Is a Subtype-Selective PPARβ/δ Agonist.
    Zhao S; Kanno Y; Li W; Wakatabi H; Sasaki T; Koike K; Nemoto K; Li H
    J Nat Prod; 2016 Apr; 79(4):879-85. PubMed ID: 27025413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Picrasidine C as a Subtype-Selective PPARα Agonist.
    Zhao S; Kanno Y; Li W; Sasaki T; Zhang X; Wang J; Cheng M; Koike K; Nemoto K; Li H
    J Nat Prod; 2016 Dec; 79(12):3127-3133. PubMed ID: 27958735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
    Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable over-expression of PPARβ/δ and PPARγ to examine receptor signaling in human HaCaT keratinocytes.
    Borland MG; Khozoie C; Albrecht PP; Zhu B; Lee C; Lahoti TS; Gonzalez FJ; Peters JM
    Cell Signal; 2011 Dec; 23(12):2039-50. PubMed ID: 21843636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
    Naruhn S; Meissner W; Adhikary T; Kaddatz K; Klein T; Watzer B; Müller-Brüsselbach S; Müller R
    Mol Pharmacol; 2010 Feb; 77(2):171-84. PubMed ID: 19903832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D; Bianchi A; Boyault S; Sebillaud S; Koufany M; Francois M; Netter P; Jouzeau JY; Terlain B
    Arthritis Rheum; 2005 Mar; 52(3):759-69. PubMed ID: 15751073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlike PPARgamma, PPARalpha or PPARbeta/delta activation does not promote human monocyte differentiation toward alternative macrophages.
    Bouhlel MA; Brozek J; Derudas B; Zawadzki C; Jude B; Staels B; Chinetti-Gbaguidi G
    Biochem Biophys Res Commun; 2009 Aug; 386(3):459-62. PubMed ID: 19527689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
    Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
    Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor β/δ and γ agonists differentially affect prostaglandin E2 and cytokine synthesis and nutrient transporter expression in porcine trophoblast cells during implantation.
    Blitek A; Szymanska M
    Theriogenology; 2020 Aug; 152():36-46. PubMed ID: 32361305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of peroxisome proliferator-activated receptor isoforms alpha, beta/delta, and gamma mediate distinct facets of hypertrophic transformation of adult cardiac myocytes.
    Pellieux C; Montessuit C; Papageorgiou I; Lerch R
    Pflugers Arch; 2007 Dec; 455(3):443-54. PubMed ID: 17643263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
    Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
    Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses.
    Aleshin S; Strokin M; Sergeeva M; Reiser G
    Neurochem Int; 2013 Oct; 63(4):322-30. PubMed ID: 23811400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
    Naruhn S; Toth PM; Adhikary T; Kaddatz K; Pape V; Dörr S; Klebe G; Müller-Brüsselbach S; Diederich WE; Müller R
    Mol Pharmacol; 2011 Nov; 80(5):828-38. PubMed ID: 21862691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome-proliferator-activated receptors γ and β/δ mediate vascular endothelial growth factor production in colorectal tumor cells.
    Röhrl C; Kaindl U; Koneczny I; Hudec X; Baron DM; König JS; Marian B
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):29-39. PubMed ID: 20221637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiolic acid activates the expression of the PPARβ/δ target genes in MDA-MB-231 cells.
    Hirao-Suzuki M; Takayuki K; Takiguchi M; Peters JM; Takeda S
    Arch Biochem Biophys; 2022 Nov; 731():109428. PubMed ID: 36228705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
    Palkar PS; Borland MG; Naruhn S; Ferry CH; Lee C; Sk UH; Sharma AK; Amin S; Murray IA; Anderson CR; Perdew GH; Gonzalez FJ; Müller R; Peters JM
    Mol Pharmacol; 2010 Sep; 78(3):419-30. PubMed ID: 20516370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
    Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
    Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling.
    Stockert J; Adhikary T; Kaddatz K; Finkernagel F; Meissner W; Müller-Brüsselbach S; Müller R
    Nucleic Acids Res; 2011 Jan; 39(1):119-31. PubMed ID: 20846954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.